Dr. Kelly Olino was born in Queens, New York, and earned her BS from Cornell University in Biological Sciences and her MD from the Johns Hopkins School of Medicine where she completed her residency in General Surgery. She completed a three year T32 research fellowship in tumor immunology during her residency training and was awarded the Anthony Imbembo Resident Teaching Award three times. Dr. Olino went on to complete a clinical fellowship at the Memorial Sloan Kettering Cancer Center in New York City where in collaboration with Diane Reidy, MD, she conceived of and wrote a human clinical trial using pembrolizumab for the treatment of adrenocortical carcinoma which is currently accruing patients.
Dr. Olino is currently a Provost Scholar at the University of Texas Medical Branch at Galveston where she is an Assistant Professor of Surgery. Dr. Olino is developing the tumor immunology program and currently focusing on utilizing nanofiber technology to develop cancer vaccines directed at melanoma.
Johns Hopkins School of Medicine - Baltimore, MD, MD, 2005
General Surgery, Johns Hopkins Hospital - Baltimore, MD, 2013
Surgical Oncology, Memorial Sloan Kettering Cancer Center - New York, NY, 2015
General Surgery, Johns Hopkins Hospital - Baltimore, MD, 2006
General Surgery,American Board of Surgery
Complex General Surgical Oncology,American Board of Surgery
Texas Department of Criminal Justice
UTMB Health General Surgery - Galveston
1005 Harborside Drive
Galveston, TX 77550
Fax: (409) 772-4456